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Abstract
Aim To evaluate the effect of high-frequency jet ventila-
tion (HFJV) in place of standard intermittent positive-
pressure ventilation (IPPV) on procedure duration, patient
radiation dose, complication rates, and outcomes during
CT-guided cryoablation of small renal tumours.
Materials and Methods One hundred consecutive CT-
guided cryoablation procedures to treat small renal tumours
under general anaesthesia were evaluated—50 with stan-
dard IPPV and 50 after the introduction of HFJV as stan-
dard practice. Anaesthesia and procedural times, ionising
radiation dose, complications, and 1-month post-treatment
outcomes were collected.
Results HFJV was feasible and safe in all cases. Mean
procedure time and total anaesthetic time were shorter with
HFJV (p =\0.0001). The number of required CT acqui-
sitions (p = 0.0002) and total procedure patient radiation
dose (p = 0.0027) were also lower in the HFJV group
compared with the IPPV group. There were a total of four
complications of Clavien–Dindo classification 3 or
above—three in the IPPV group and one in the HFJV
group. At 1-month follow-up, two cases (both in the IPPV
group) demonstrated subtotal treatment. Both cases were
subsequently successfully retreated with cryoablation.
Conclusion By reducing target tumour motion during CT-
guided renal cryoablation, HFJV can reduce procedure
times and exposure to ionising radiation. HFJV provides an
important adjunct to complex image-guided interventions,
with potential to improve safety and treatment outcomes.
Keywords Kidney  Cancer  Cryoablation 
Ventilation  Computed Tomography
Introduction
Modern management of small renal masses has moved
towards nephron-sparing techniques—that include partial
nephrectomy (PN) and image-guided ablation (IGA). IGA
allows minimally invasive tumour destruction with signif-
icantly reduced patient impact [1], preserved renal function
[2], and oncological outcomes that are equivalent to sur-
gical resection [3].
Minimising rates of local recurrence following IGA
requires diligent technique to ensure ablative energy is
delivered precisely to the tumour with an appropriate
margin. Cryoablation (CYA) has become the technique of
choice, with multiple probes carefully positioned simulta-
neously within the tumour to produce a conformal treat-
ment zone or ‘iceball’ that can be visually confirmed on
intra-operative CT or MRI.
Despite immobilisation with general anaesthesia, tradi-
tional intermittent positive-pressure ventilation (IPPV)
causes significant abdominal organ motion making tumour
targeting more difficult [4]. Probes must be inserted
between respiratory cycles or during short periods of
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apnoea—often requiring additional image acquisitions and
extending procedure length.
High-frequency jet ventilation (HFJV) delivers contin-
uous small tidal volume ventilation at high frequency
resulting in a near stationary diaphragm and minimal target
organ motion [5–8]. Several studies have reported a
reduction in technical difficulty associated with probe
placement, procedure time, and patient radiation dose
during image-guided interventions and single-probe ther-
mal ablation of metastatic tumours in the liver and lung
[9–11]. HFJV has the potential to simplify renal tumour
cryoablation, where multiple simultaneous probe place-
ments are required, and where treatment margins must be
adequate but not excessive to preserve renal function [12].
The aim of this study was to evaluate the effect of HFJV
in place of standard IPPV on procedure duration, patient
radiation dose, and complication rates during CT-guided
cryoablation of small renal tumours.
Methods
Study Design
This retrospective review was undertaken at a single ter-
tiary interventional oncology (IO) centre with prior expe-
rience of over 150 renal tumour cryoablation cases. The IO
team had also completed eight CT-guided ablation proce-
dures (five lung and three liver) using HFJV before this
study. One hundred consecutive patients undergoing CT-
guided cryoablation of a small renal tumour under general
anaesthesia between December 2015 and January 2017
were evaluated—50 with standard IPPV and 50 after the
introduction of HFJV as standard practice at this centre.
The study was reviewed by the University College London
and University College London Hospitals joint research
and development office and considered to be service
evaluation exempt from research ethics committee
approval.
The decision to treat with CYA was made at the local
renal cancer network multidisciplinary team meeting. All
patients gave fully informed consent, and in all cases,
treatment was performed with curative intent. The primary
outcome for this study was procedure duration. Secondary
outcomes included: probe placement time, patient radiation
dose (represented by dose length product (DLP) generated
automatically at the scanner console), number of CT
acquisitions (fluoroscopic acquisitions required for needle
insertion), and complication rates (anaesthetic, medical or
surgical score according to the Clavien–Dindo scale) fol-
lowing CT-guided cryoablation of small renal tumours.
Anaesthetic Protocol
All patients were subject to anaesthetic pre-assessment and
were classified per the physical status classification system
of the American Society of Anaesthesiologists (ASA).
General anaesthesia was induced by one of two anaes-
thetists with 1–2 mg midazolam, followed by a total
intravenous anaesthesia target controlled intravenous
infusion of propofol (maintenance range 1.8–6 mcg/ml)
and remifentanil (0.2–8 ng/ml). After muscle relaxation,
patients were intubated orally and a reinforced endotra-
cheal tube (ETT) inserted. The patients were then posi-
tioned in the CT scanner to allow optimal tumour access in
either a prone or lateral position.
All patients were initially ventilated with conventional
volume- or pressure-controlled intermittent positive-pres-
sure ventilation, via a standard circle anaesthetic breathing
system using a Datex Aestiva anaesthetic machine. For
those patients in the HFJV group, a jet swivel adaptor
(Acutronic Medical Systems) was introduced into the cir-
cuit between the patient’s cuffed oral endotracheal tube
(ETT) and the anaesthetic breathing circuit.
HFJV was commenced at 100–120 breaths per minute,
with a driving pressure (DP) of 1.0 bar. DP was adjusted to
maintain the end-tidal carbon dioxide between 4.5 and
5.5 kPa using intermittent checks measured through IPPV
via the anaesthetic machine capnography device (GE
Healthcare gas module E-CAi0-00 (Helsinki, Finland)).
Once CYA treatment was complete, the patients were
ventilated conventionally until awake.
CT Protocol
All renal cryoablation procedures were performed in a
dedicated interventional CT suite (Toshiba Prime, Toshiba
Medical Systems, Japan, 2014) following the standard CT-
guided renal cryoablation protocol at our institution.
Patients were positioned in either the prone or lateral
position to allow optimal target tumour access—confirmed
using a low-dose unenhanced positioning CT scan. A dual
(arterial and venous)-phase CT scan of the kidneys was
performed to plan probe placement and adjunctive hydro-
or pneumo-dissection.
The CT fluoroscopic package in intermittent biopsy
mode was used for guidance of cryoprobe placement (Galil
Medical System, Minneapolis, USA). Each acquisition
comprised a volume (100 kV, 30 mA with 0.5 s gantry
rotation) reconstructed into three congruent 4 mm slices.
Final cryoprobe placement was confirmed with a low-dose
scan volume of the target organ before commencement of
treatment with a double freeze (10 min) and thaw (6 min
passive and 2 min active) protocol. During each cycle,
low-dose scans of the target organ were obtained at 5 and
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10 min to monitor the ice ball formation. A final low-dose
post-procedure scan was performed following cryoprobe
removal as a safe check to look for immediate complica-
tions such as haemorrhage or pneumo-thorax. Hydrodis-
section was administered when required using a 21-gauge
spinal needle to infuse sterile saline containing Omnipaque
at a ratio of 20 per 1000 ml of saline. Hydrodissection
needles were left in situ during treatment cycles.
All helical scans used the following standard parame-
ters: 100 kV tube potential, automatic tube current modu-
lation with a range of 40–180 mA, 0.5 s gantry rotation,
0.5 detector collimation, a pitch factor of 0.813, a helical
pitch of 65, and iterative reconstruction with 1 mm slice
thickness.
For each procedure, data related to procedure duration,
patient-ionising radiation dose, technical difficulty, and
complications were collected. Technical difficulty was
assessed through the surrogate measures of probe place-
ment time and total number of CT acquisitions for probe
placement. Total ionising radiation dose was recorded as
dose length product (DLP) generated automatically at the
scanner console.
Anaesthetic induction time was defined as the period
from initiating induction of anaesthesia to commencement
of the positioning scan, and total procedure time was
defined as time from positioning scan to the final treatment
confirmation scan. The number of cryoprobes, hydro- and
pneumo-dissection needles used, number of biopsy-mode
CT volume acquisitions, and total time required to place
the probes and needles were also recorded.
Patient Follow-Up
All patients were admitted overnight for observation and if
standard hospital discharge criteria met, discharged the
following morning. Patients were reviewed in an outpatient
clinic at 1 month post-treatment with renal contrast-en-
hanced CT. Treatment was considered successful if at
1 month post-procedure, the ablation zone encompassed
the target tumour with a margin greater than 5 mm in all
planes, and with no tumour enhancement [13]. All com-
plications within 30 days of treatment were recorded and
scored using the Clavien–Dindo classification system.
Statistical Analysis
Data between IPPV and HFJV groups were compared
using unpaired t tests. A p value of 0.05 or lower was
considered statistically significant. IPPV and HFJV groups
were assessed for normal distribution using Kolmogorov–
Smirnov tests. Nonparametric data between groups were
compared using Mann–Whitney U test. All statistical tests
were carried out using PRISM (GraphPad Software, San
Diego, Calif).
Results
During the review period, 100 renal tumours were treated
by CT-guided cryoablation in 100 separate treatment ses-
sions involving 95 patients. Fifty treatments were per-
formed using IPPV and 50 using HFJV. No patients were
excluded from the analysis, and patient records and data
were available for all cases. None of the patients intended
for HFJV required a switch in ventilation technique to
IPPV. Treatment was successfully completed (technical
success) in all cases at the time of procedure. However, at
1-month follow-up, subtotal treatment was found in two
patients in the IPPV group, requiring retreatment of
cryoablation. None of the patients treated using HFJV
required repeat treatment.
Patient demographics and tumour characteristics are
summarised in Tables 1 and 2, with comparable charac-
teristics and ASA classification between groups. Table 3
summarises details of treatment sessions including patient
position, anaesthetic induction time, number of cryoprobes
placed, and the use of hydro- and pneumo-dissec-
tion. Comparison between groups showed no statistically
significant difference in these variables. Mean total pro-
cedure time was 144 min (SD 37.32) for IPPV versus
106 min (SD 29.69) for HFJV (p =\0.0001) (Fig. 1), and
mean needle placement time was 100 min (SD 38.24) for
IPPV versus 66 min (SD 27.83) for HFJV
(p =\0.0001) (Fig. 2). The number of CT acquisitions
required for needle placement was 78.8 (SD 29.02) for
IPPV versus 59.2 (SD 21.98) for HFJV
(p = 0.0002) (Table 4), and total procedure patient radia-
tion dose 1975 mGycm2 (SD 1055) for IPPV versus 1449
mGycm2 (SD 597.4) for HFJV (p = 0.0027) (Fig. 3).
Table 1 Patient demographic details—mean (range)
IPPV group HFJV group
Number of procedures 50 50
Sex
Male 35 39
Female 15 11
Age (years) 64 (28–86) 69 (41–85)
Weight (Kg) 91 (73–138) 85 (65–128)
Height (metres) 1.70 (1.56–1.91) 169 (1.5–1.87)
Body mass index (kg/m2) 31.4 (22.2–43) 29.5 (21.1–42.2)
ASA 2.54 2.68
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There were no complications or delays to discharge
attributable to ventilation technique. There were no deaths
within the 30-day follow-up period. There were 17 com-
plications, four of which with Clavien–Dindo (CD) score
of 3 or above. These were one case of transient brachial
plexus injury (CD3) which resolved without intervention;
one urine leak (CD3b), managed conservatively with
insertion of a ureteric stent; one case of haematuria
(CD3a), requiring bladder irrigation via a three-way
catheter; and one patient developed a right-sided pul-
monary embolus (CD4a) requiring an ITU admission and
delaying discharge by 15 days.
At 1-month follow-up imaging, two cases (both in the
IPPV group) demonstrated subtotal treatment. Both cases
were subsequently successfully retreated with cryoablation.
Discussion
Image-guided ablation has established itself within the
toolbox of modern oncology. For small renal tumours,
advances in technique, image guidance, and ablation
technology allow image-guided ablation (IGA) with
equivalent oncological outcomes to surgery [3], and IGA
has moved away from being used only in high-risk surgical
groups to an effective primary therapy for localised cancer
[13, 14]. Technique development is now focused on
achieving more robust, consistent, and cost-effective
delivery of treatment [15], with improved tumour targeting
a crucial factor in achieving these aims.
By reducing target organ motion, HFJV has potential to
reduce technical difficulty associated with treatment probe
placement in solid organs such as the liver and kidney,
thereby improving tumour targeting and accuracy.
IPP
V 
HF
JV
0
50
100
150
200
P < 0.0001
To
ta
l p
ro
ce
du
re
 ti
m
e 
(m
in
s)
Fig. 1 Box-and-whisker plot showing total procedure time (mean
and standard deviation) in minutes for the two ventilation groups
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Fig. 2 Box-and-whisker plot showing needle placement time (mean
and standard deviation) in minutes for the two ventilation groups
Table 2 Baseline tumour characteristics
IPPV HFJV p value
PADUA score 7.2 7.41
Size (mm) 25.63 28.74 0.1322
Histology
Clear cell 31 35
Chromophobe 3 5
Papillary 12 8
Spindle cell 1 0
Oncocytoma 1 0
Not biopsied 2 2
Table 3 Comparison of
procedural details
IPPV HFJV p value
Patient position
Prone 38 31 –
Left lateral 5 9 –
Right lateral 7 10 –
Induction time (total anaesthesia time minus procedure time) 30 min 4 s 31 min 0.2788
Number of probes 3.922 4.24 0.3427
Hydro or pneumo-dissection 25 23 –
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Technical difficulty is problematic to quantify, but logical
surrogate measures related to procedure duration and
required level of image guidance can be evaluated.
In this retrospective review, we demonstrate that HFJV
can be safely implemented and produces a significant
reduction in procedure time, number of required CT
acquisitions, and ionising radiation dose for patients
undergoing cryoablation of small renal tumours, with no
effect on complication rate or length of inpatient stay.
CT-guided cryoablation procedures frequently place
significant pressure on CT capacity due in part to the length
of procedure. The 26% reduction in total procedure time
demonstrated here will have cost and resource benefits to
interventional oncology departments, justifying the
investment in additional equipment and training that may
be required to perform HFJV. A significant reduction in
procedure and anaesthetic time will reduce anaesthetic risk
and allow more rapid recovery [16, 17]. Reduced anaes-
thetic risk will also widen access to patients who may have
comorbidities and are unable to undergo other treatments.
Complex interventions require multiple CT acquisitions.
Modern scanners implement a range of dose sparing
techniques such as dose modulation and iterative recon-
struction; however, dose to the patient and operator during
these procedures is significant. With the current trend of
increasing numbers of IGA treatments being performed,
methods that reduce dose exposure to patient and operator
are particularly important. By reducing the number of
acquisitions required to place the probes (24%), HFJV has
a direct effect on the ionising radiation dose to the patient.
We report a 27% reduction in patient radiation dose
(DLP—mGycm2) for procedures performed under HFJV
compared with IPPV. The patient dose reduction achieved
is significant (an increasing number of whom are\ 50
years), and although not measured here, would likely lead
to a reduced scatter dose to the operator. This dose
reduction is, however, less than the 54% reduction reported
by Chung et al., achieved with HFJV during thermal
ablation of lung tumours, which may reflect the higher
number of set helical acquisitions (e.g., position checking
and treatment monitoring helical scans) within the renal
tumour treatment protocol.
We used needle placement time and number of CT
acquisitions to evaluate the ability of HFJV to reduce the
technical difficulty of CT-guided renal cryoablation by
reducing ventilatory motion. Needle placement time fell
from 100 to 66 min between groups (p =\0.0001), and
number of CT acquisitions from 78.8 to 59.2 between
groups (p =\0.0002)—giving a clear indication of the
effect of HFJV. Factors other than motion may affect
needle placement time, including depth of tumour from the
skin, tumour endophycity, and patient position. Patient
BMI, position, and tumour PADUA score were well mat-
ched between groups (Table 2), minimising this potential
bias. Although we included placement of dissection nee-
dles in the evaluation, we did not correct for variation in
the time and CT acquisitions required to achieve satisfac-
tory hydro- or pneumo-dissection.
Importantly, we demonstrate that in a representative patient
group, HFJV can be applied ubiquitously without the need for
conversion to IPPV and that establishing anaesthesia with
HFJV was safe and took no longer. The requirement for the
anaesthetic team to undergo additional training to be familiar
and confident with the use of HFJV is recognised [9], and
special arrangements were made during the evaluation period
to ensure specific anaesthetist staff were available. However,
despite the benefits described, limitations in training and staff
availability may limit use with IGA.
The use of HFJV in the prone position may be unfa-
miliar to many anaesthetic teams. Prone ventilation is used
widely in the intensive care environment to optimise PaO2:
FiO2 ratio, with no increase in risk of barotrauma, CO2
clearance, or ability to deliver tidal volumes [18]. These
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Fig. 3 Box-and-whisker plot showing total procedure dose (mean
and standard deviation) as dose length product for the two ventilation
groups
Table 4 Comparison of
time/dose/difficulty
IPPV HFJV p value
Total procedure time (minutes) 142.4 105.8 \ 0.0001
Needle placement time (time to achieve probe positions—minutes) 100.2 66.2 \ 0.0001
Number of acquisitions for probe placement 78.8 59.2 0.0002
Patient dose collected as dose length product (mGycm2) 1975 1449 0.0027
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risks are not thought to be altered by the use of HFJV in the
prone position, but this has not been specifically investi-
gated. Concerns associated with a prone position are dis-
lodging tubes and lines; abdominal discomfort and
compartment syndrome in obese patients; and nerve dam-
age associated with arm positioning and pressure point
damage rather than issues associated with the mode of
ventilation.
Patient age was also not a limitation to HFJV. Out of 95
patients in this study, 72 were aged over 60 years. We
experienced no issues with hypercapnoea, acidosis, or tube
placement that required intervention or deviation from our
predetermined protocol. Severe COPD has been considered
to be a relative contraindication to HFJV, due to the
potential risk of gas trapping and barotrauma in this pop-
ulation; however, in the range of lung function normally
acceptable for ablation under general anaesthesia at our
institution (i.e., an FEV1[ 1L), this has not thus far been
a significant concern. Further studies are however required
to specifically explore the acceptability of this technique in
patients with severe cardiorespiratory disease to determine
whether any patient cohorts should be precluded from
HFJV in the prone and lateral positions.
There were several further limitations to this study. The
review was conducted retrospectively and without ran-
domisation and therefore potentially subject to several
sources of bias. However, the compared groups did consist
of consecutively treated patients, with good matching of
key patient and tumour characteristics and no missing
data—thus allowing meaningful comparison between the
HFJV and the IPPV control group. Although sufficient to
demonstrate change in the endpoints assessed here, the case
numbers were relatively small, and not sufficient to probe
differences in technical success or complication rate.
The post-treatment follow-up period was also short
(1 month) and insufficient to demonstrate any effect on
treatment efficacy. We hypothesise that reduced tumour
motion and more accurate targeting would lead to higher
treatment efficacy and improved oncological outcomes, but
this requires future investigation.
Conclusion
By reducing target tumour motion during CT-guided renal
cryoablation, HFJV can reduce the technical difficulty
associated with probe insertion—leading to reduced pro-
cedure times and exposure to ionising radiation. HFJV
provides an important adjunct to complex image-guided
interventions, with potential to improve safety, treatment
outcomes and extend the scope of IGA therapies; however,
further studies are required to evaluate these effects.
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